Yahoo! Finance: Biotechnology Industry News: Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc.

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Subscribe to Bloomberg Businessweek Get Bloomberg Businessweek for 84% off what others pay on the newsstand - that's like getting 38 complimentary issues! Sign up today. From our sponsors

Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. Oct 26th 2013, 01:32 [Business Wire] - Glancy Binkow & Goldberg LLP announces that all purchasers of the securities of ARIAD Pharmaceuticals, Inc. between December 12, 2011 and October 8, 2013, inclusive have until December 9, 2013, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the District of Massachusetts.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions